A Study to Examine the Effect of Daridorexant on the Way the Body Absorbs, Distributes, and Gets Rid of Midazolam and Warfarin in Healthy Male Subjects
Clinical trial NCT05480488 · COMPLETED
Trial details
- NCT number
- NCT05480488
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-23
- Primary completion
- 2022-09-23
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.